Pomalidomide, Dexamethasone and Pegylated Liposomal Doxorubicin for Relapsed/Refractory Multiple Myeloma
Public ClinicalTrials.gov record NCT01541332. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1/2 Study of Pomalidomide, Dexamethasone and Pegylated Liposomal Doxorubicin for Patients With Relapsed/Refractory Multiple Myeloma
Study identification
- NCT ID
- NCT01541332
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- Oncotherapeutics
- Industry
- Enrollment
- 70 participants
Conditions and interventions
Conditions
Interventions
- Pomalidomide Drug
- Pegylated Liposomal Doxorubicin (PLD) Drug
- Dexamethasone Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2012
- Primary completion
- Nov 30, 2016
- Completion
- Nov 30, 2016
- Last update posted
- Mar 9, 2016
2012 – 2016
United States locations
- U.S. sites
- 8
- U.S. states
- 2
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Roy and Patricia Disney Family Cancer Center | Burbank | California | 91505 | — |
| California Cancer Associates for Research and Excellence | Encinitas | California | 92024 | — |
| Hematology Oncology Medical Group | Fresno | California | 93720 | — |
| Pacific Cancer Care | Salinas | California | 93901 | — |
| Cancer Center of Santa Barbara | Santa Barbara | California | 93105 | — |
| Mission Hope Cancer Center | Santa Maria | California | 93454 | — |
| James R Berenson, MD, Inc. | West Hollywood | California | 90069 | — |
| Illinois Cancer Specialists | Niles | Illinois | 60714 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01541332, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 9, 2016 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01541332 live on ClinicalTrials.gov.